-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PIqUeALmY1GLtUVF5knx2xBixvPeHqbwgOGJhBk75aNGbwcv4wNg3RBI2vCvUiZN F13BrvvHxUYuSbekXCW5Fg== 0000950123-10-006125.txt : 20100128 0000950123-10-006125.hdr.sgml : 20100128 20100128155009 ACCESSION NUMBER: 0000950123-10-006125 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100128 DATE AS OF CHANGE: 20100128 GROUP MEMBERS: JAMES JONES GROUP MEMBERS: KATE MITCHELL GROUP MEMBERS: LOUIS C. BOCK GROUP MEMBERS: MARK BROOKS GROUP MEMBERS: RORY O'DRISCOLL GROUP MEMBERS: SCALE VENTURE MANAGEMENT II, LLC GROUP MEMBERS: SHARON WIENBAR SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Orexigen Therapeutics, Inc. CENTRAL INDEX KEY: 0001382911 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 651178822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-83422 FILM NUMBER: 10553919 BUSINESS ADDRESS: STREET 1: 3344 N. TORREY PINES CT. STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 875-8600 MAIL ADDRESS: STREET 1: 3344 N. TORREY PINES CT. STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Scale Venture Partners II, LP CENTRAL INDEX KEY: 0001314703 IRS NUMBER: 201965001 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 950 TOWER LANE CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650.378.6050 MAIL ADDRESS: STREET 1: 950 TOWER LANE CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: BAVP VII LP DATE OF NAME CHANGE: 20050119 SC 13G/A 1 f54747sc13gza.htm SC 13G/A sc13gza

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934
(Amendment No. 2)*

Orexigen Therapeutics, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
68616404
(CUSIP Number)
12/31/09
(Date of Event Which Requires Filing of This Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     o Rule 13d-1(b)

     o Rule 13d-1(c)

     þ Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 


 

                     
CUSIP No.
 
68616404
 

 

           
1.   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Scale Venture Partners II, LP 20-1965001
     
     
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3.   SEC USE ONLY
   
   
     
4.   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5.   SOLE VOTING POWER
     
NUMBER OF   3,042,445*
       
SHARES 6.   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7.   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   3,042,445*
       
WITH: 8.   SHARED DISPOSITIVE POWER
     
    0
     
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  3,042,445*
     
10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  6.5%
     
12.   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN
* Includes 25,000 shares one of the managing members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP, has the right to acquire within 60 days of 12/31/09 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such managing member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

Page 2 of 14 pages


 

                     
CUSIP No.
 
68616404 
 

 

           
1.   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Scale Venture Management II, LLC 27-0110811
     
     
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3.   SEC USE ONLY
   
   
     
4.   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  California
       
  5.   SOLE VOTING POWER
     
NUMBER OF   3,042,445*
       
SHARES 6.   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7.   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   3,042,445*
       
WITH: 8.   SHARED DISPOSITIVE POWER
     
    0
     
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  3,042,445*
     
10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  6.5%
     
12.   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  CO
* Shares are held by Scale Venture Partners II, LP. Scale Venture Management II, LLC is the general partner of Scale Venture Partners II, LP. Includes 25,000 shares one of the managing members of Scale Venture Management II, LLC has the right to acquire within 60 days of 12/31/09 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such managing member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

Page 3 of 14 pages


 

                     
CUSIP No.
 
68616404 
 

 

           
1.   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Louis C. Bock
     
     
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3.   SEC USE ONLY
   
   
     
4.   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  US
       
  5.   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6.   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   3,042,445*
       
EACH 7.   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8.   SHARED DISPOSITIVE POWER
     
    3,042,445*
     
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  3,042,445*
     
10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  6.5%
     
12.   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
* Shares are held by Scale Venture Partners II, LP. Louis C. Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. The Reporting Person disclaims beneficial ownership with respect to all such shares except to the extent of his proportionate pecuniary interests therein. Includes 25,000 shares the reporting person has the right to acquire within 60 days of 12/31/09 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such managing member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

Page 4 of 14 pages


 

                     
CUSIP No.
 
68616404 
 

 

           
1.   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Kate Mitchell
     
     
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3.   SEC USE ONLY
   
   
     
4.   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  US
       
  5.   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6.   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   3,042,445*
       
EACH 7.   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8.   SHARED DISPOSITIVE POWER
     
    3,042,445*
     
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  3,042,445*
     
10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  6.5%
     
12.   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
* Shares are held by Scale Venture Partners II, LP. Louis C. Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. The Reporting Person disclaims beneficial ownership with respect to all such shares except to the extent of her proportionate pecuniary interests therein. Includes 25,000 shares one of the managing members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP, has the right to acquire within 60 days of 12/31/09 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such managing member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

Page 5 of 14 pages


 

                     
CUSIP No.
 
68616404 
 

 

           
1.   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Rory O’Driscoll
     
     
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3.   SEC USE ONLY
   
   
     
4.   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  US
       
  5.   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6.   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   3,042,445*
       
EACH 7.   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8.   SHARED DISPOSITIVE POWER
     
    3,042,445*
     
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  3,042,445*
     
10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  6.5%
     
12.   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
* Shares are held by Scale Venture Partners II, LP. Louis C. Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. The Reporting Person disclaims beneficial ownership with respect to all such shares except to the extent of his proportionate pecuniary interests therein. Includes 25,000 shares one of the managing members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP, has the right to acquire within 60 days of 12/31/09 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such managing member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

Page 6 of 14 Pages


 

                     
CUSIP No.
 
68616404 
 

 

           
1.   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Mark Brooks
     
     
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3.   SEC USE ONLY
   
   
     
4.   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  US
       
  5.   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6.   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   3,042,445*
       
EACH 7.   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8.   SHARED DISPOSITIVE POWER
     
    3,042,445*
     
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  3,042,445*
     
10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  6.5%
     
12.   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
* Shares are held by Scale Venture Partners II, LP. Louis C. Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. The Reporting Person disclaims beneficial ownership with respect to all such shares except to the extent of his proportionate pecuniary interests therein. Includes 25,000 shares one of the managing members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP, has the right to acquire within 60 days of 12/31/09 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such managing member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

Page 7 of 14 pages


 

                     
CUSIP No.
 
68616404 
 

 

           
1.   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
James Jones
     
     
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3.   SEC USE ONLY
   
   
     
4.   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  US
       
  5.   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6.   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   3,042,445*
       
EACH 7.   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8.   SHARED DISPOSITIVE POWER
     
    3,042,445*
     
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  3,042,445*
     
10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  6.5%
     
12.   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
* Shares are held by Scale Venture Partners II, LP. Louis C. Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. The Reporting Person disclaims beneficial ownership with respect to all such shares except to the extent of his proportionate pecuniary interests therein. Includes 25,000 shares one of the managing members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP, has the right to acquire within 60 days of 12/31/09 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such managing member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

Page 8 of 14 pages


 

                     
CUSIP No.
 
68616404 
 

 

           
1.   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Sharon Wienbar
     
     
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3.   SEC USE ONLY
   
   
     
4.   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  US
       
  5.   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6.   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   3,042,445*
       
EACH 7.   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8.   SHARED DISPOSITIVE POWER
     
    3,042,445*
     
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  3,042,445*
     
10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  6.5%
     
12.   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
* Shares are held by Scale Venture Partners II, LP. Louis C. Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. The Reporting Person disclaims beneficial ownership with respect to all such shares except to the extent of her proportionate pecuniary interests therein. Includes 25,000 shares one of the managing members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP, has the right to acquire within 60 days of 12/31/09 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such managing member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

Page 9 of 14 pages


 

Item 1.
  (a)   Name of Issuer
 
      Orexigen Therapeutics, Inc.
  (b)   Address of Issuer’s Principal Executive Offices
      3344 N. Torrey Pines Ct., Suite 200
La Jolla, CA 92037
 
     
Item 2.
  (a)   Name of Person Filing
 
      Scale Venture Partners II, LP; Scale Venture Management II, LLC; Louis C. Bock; Kate Mitchell; Rory O’ Driscoll; Mark Brooks; James Jones and Sharon Wienbar
  (b)   Address of Principal Business Office or, if none, Residence
 
      Scale Venture Partners II, LP: 950 Tower Lane, Suite 700, Foster City, CA 94404
 
      Scale Venture Management II, LLC:950 Tower Lane, Suite 700, Foster City, CA 94404
     
Louis C. Bock:
  950 Tower Lane, Suite 700, Foster City, CA 94404
Kate Mitchell:
  950 Tower Lane, Suite 700, Foster City, CA 94404
Rory O’Driscoll:
  950 Tower Lane, Suite 700, Foster City, CA 94404
Mark Brooks:
  950 Tower Lane, Suite 700, Foster City, CA 94404
James Jones:
  950 Tower Lane, Suite 700, Foster City, CA 94404
Sharon Wienbar:
  950 Tower Lane, Suite 700, Foster City, CA 94404
  (c)   Citizenship
 
      Scale Venture Partners II, LP is organized in Delaware and Scale Venture Management II, LLC is organized in California. Each of Louis C. Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are US citizens.
  (d)   Title of Class of Securities
 
      Common Stock
  (e)   CUSIP Number
 
      68616404
Item 3.    If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
          Not applicable
Item 4.   Ownership
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
             
(a)
  Amount Beneficially Owned:        
 
  Scale Venture Partners II, LP     3,042,445 (1)
 
  Scale Venture Management II, LLC     3,042,445 (1)
 
  Louis C. Bock     3,042,445 (1)

Page 10 of 14 pages


 

             
 
  Kate Mitchell     3,042,445 (1)
 
  Rory O’Driscoll     3,042,445 (1)
 
  Mark Brooks     3,042,445 (1)
 
  James Jones     3,042,445 (1)
 
  Sharon Wienbar     3,042,445 (1)
 
           
(b)
  Percent of Class:        
 
  Scale Venture Partners II, LP     6.5 %
 
  Scale Venture Management II, LLC     6.5 %
 
  Louis C. Bock     6.5 %
 
  Kate Mitchell     6.5 %
 
  Rory O’Driscoll     6.5 %
 
  Mark Brooks     6.5 %
 
  James Jones     6.5 %
 
  Sharon Wienbar     6.5 %
             
(c)
  Number of shares as to which the person has:        
 
  (i) Sole power to vote or to direct the vote:        
 
           
 
  Scale Venture Partners II, LP     3,042,445 (1)
 
  Scale Venture Management II, LLC     3,042,445 (1)
 
           
 
  (ii) Shared power to vote or to direct the vote:        
 
           
 
  Louis C. Bock     3,042,445 (1)
 
  Kate Mitchell     3,042,445 (1)
 
  Rory O’Driscoll     3,042,445 (1)
 
  Mark Brooks     3,042,445 (1)
 
  James Jones     3,042,445 (1)
 
  Sharon Wienbar     3,042,445 (1)
 
           
 
  (iii) Sole power to dispose or to direct the disposition of:        
 
           
 
  Scale Venture Partners II, LP     3,042,445 (1)
 
  Scale Venture Management II, LLC     3,042,445 (1)
 
           
 
  (iv) Shared power to dispose or to direct the disposition of:        
 
           
 
  Louis C. Bock     3,042,445 (1)
 
  Kate Mitchell     3,042,445 (1)
 
  Rory O’Driscoll     3,042,445 (1)
 
  Mark Brooks     3,042,445 (1)
 
  James Jones     3,042,445 (1)
 
  Sharon Wienbar     3,042,445 (1)
 
(1)   Shares are held by Scale Venture Partners II, LP. Scale Venture Management II, LLC is the General Partner of Scale Venture Partners II, LP. Louis Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. Includes 25,000 shares one of the managing members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP, has the right to acquire within 60 days of 12/31/09 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such managing member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

Page 11 of 14 pages


 

Item 5.    Ownership of Five Percent or Less of a Class
          Not Applicable
Item 6.    Ownership of More than Five Percent on Behalf of Another Person
          Not Applicable
Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
          Not Applicable
Item 8.    Identification and Classification of Members of the Group
          Not Applicable
Item 9.    Notice of Dissolution of a Group
          Not Applicable
Item 10.    Certification
          Not applicable
[SIGNATURE]
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: January 27, 2010
                   
SCALE VENTURE PARTNERS II, LP       SCALE VENTURE MANAGEMENT II, LLC  
 
                 
By:
  Scale Venture Management II, LLC,
its General Partner
             
 
                 
By:
  /s/ Louis C. Bock       By:   /s/ Louis C. Bock  
 
                 
 
  Name: Louis C. Bock
Title:   Managing Member
          Name: Louis C. Bock
Title:   Managing Member
 
 
                 
By:
  /s/ Louis C. Bock       By:   /s/ Kate Mitchell  
 
                 
 
  Name: Louis C. Bock           Name: Kate Mitchell  

Page 12 of 14 pages


 

                   
By:
  /s/ Rory O’Driscoll       By:   /s/ Mark Brooks  
 
                 
 
  Name: Rory O’Driscoll           Name: Mark Brooks  
 
                 
By:
  /s/ James Jones       By:   /s/ Sharon Wienbar  
 
                 
 
  Name: James Jones           Name: Sharon Wienbar  
EXHIBITS
A: Joint Filing Agreement

Page 13 of 14 pages


 

EXHIBIT A
JOINT FILING AGREEMENT
     In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Orexigen Therapeutics, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.
     In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 27th day of January, 2010.
                     
SCALE VENTURE PARTNERS II, LP   SCALE VENTURE MANAGEMENT II, LLC
 
                   
By:
  Scale Venture Management II, LLC,
its General Partner
                
 
                   
By:
  /s/ Louis C. Bock   By:   /s/ Louis C. Bock        
 
                   
 
  Name: Louis C. Bock
Title:   Managing Member
      Name: Louis C. Bock
Title:   Managing Member
       
 
                   
By:
  /s/ Louis C. Bock   By:   /s/ Kate Mitchell        
 
                   
 
  Name: Louis C. Bock       Name: Kate Mitchell        
 
                   
By:
  /s/ Rory O’Driscoll   By:   /s/ Mark Brooks        
 
                   
 
  Name: Rory O’Driscoll       Name: Mark Brooks        
 
                   
By:
  /s/ James Jones   By:   /s/ Sharon Wienbar        
 
                   
 
  Name: James Jones       Name: Sharon Wienbar        

Page 14 of 14 pages

-----END PRIVACY-ENHANCED MESSAGE-----